Enzymatic Production Of A Protein Or Polypeptide (e.g., Enzymatic Hydrolysis, Etc.) Patents (Class 435/68.1)
-
Publication number: 20140120576Abstract: The invention relates to a nucleic acid which is stabilised against decomposition by exonucleases. Said nucleic acid contains the following constituents: a) a code sequence coding for a defined protein, b) optionally, a promoter sequence controlling the expression of the code sequence, and c) at least one molecule A added to an end of the linear sequence containing the constituents a and b, said molecule being linked to a non-immobilised, volumic molecule B.Type: ApplicationFiled: June 20, 2013Publication date: May 1, 2014Applicant: SIEMENS BUILDING TECHNOLOGIES AGInventors: Helmut Merk, Wolfgang Stiege
-
Publication number: 20140113830Abstract: An object of the present invention is to provide a method of efficiently constructing a library abundant in diversity and also usable for screening of a compound that binds to a target substance having protease activity. The present invention provides a method of constructing an azoline compound library containing two or more azoline compounds having an azoline backbone introduced into at least one of Cys, Ser, Thr, and 2,3-diamino acid, and analogs thereof of Xaa0 of a peptide represented by the following formula (I): A-(Xaa0)n-B??(I) [wherein, m numbers of Xaa0s respectively represent arbitrary amino acids, at least one of which is an amino acid selected from the group consisting of Cys, Ser, Thr, and 2,3-diamino acid, and analogs thereof, m represents an inter selected from 2 to 40, and A and B each independently represent a peptide composed of from 0 to 100 amino acids].Type: ApplicationFiled: March 9, 2012Publication date: April 24, 2014Applicant: THE UNIVERSITY OF TOKYOInventors: Hiroaki Suga, Yuki Goto, Yumi Ito
-
Publication number: 20140113861Abstract: The present invention relates to a method for preparing a cartilage product comprising a protein hydrolysate with a degree of hydrolysis comprised between 0.5% and 3.0%, at least one glycosaminoglycan and at least one growth factor. The present invention also relates to the cartilage product obtainable through said method. Said cartilage product is useful in the treatment or prevention of wounds, ulcers, burns, psoriasis, osteoarthritis, synovitis, osteoporosis, osteopenia, diseases of the tendons and ligaments, periodontal diseases, signs of skin aging, the harmful effects of ultraviolet radiation exposure or stretch marks.Type: ApplicationFiled: April 16, 2012Publication date: April 24, 2014Applicant: BIOIBERICA, S.A.Inventors: Josep Escaich Ferrer, Pere Dalmau Castanares, Ana Maria Torrent Gibert, Ramon Ruhi Roura, Carlos Raul Alaez Verson
-
Publication number: 20140112922Abstract: The present invention relates to an isolated chimeric molecule comprising a degradation domain including a eukaryotic U-box motif and a targeting domain capable of immuno specifically directing the degradation domain to a substrate where the targeting domain is heterologous to the degradation domain. A linker couples the degradation domain to the targeting domain. Also disclosed are compositions as well as methods of treating a disease, substrate silencing, screening agents for therapeutic efficacy against a disease, and methods of screening for disease biomarkers.Type: ApplicationFiled: March 28, 2012Publication date: April 24, 2014Applicant: CORNELL UNIVERSITYInventors: Matthew Delisa, Jeffrey Varner, Alyse Portnoff
-
Patent number: 8703459Abstract: Disclosed are mutants of galactosyltransferases that can catalyze formation of oligosaccharides in the presence of magnesium; mutants of galactosyltransferases having altered donor and acceptor specificity which can catalyze formation of oligosaccharides in the presence of magnesium; methods and compositions that can be used to synthesize oligosaccharides; methods for increasing the immunogenicity of an antigen; and methods to stabilize platelets.Type: GrantFiled: December 6, 2004Date of Patent: April 22, 2014Assignee: The United States of America, as represented by the Secretary, Department of Health & Human ServicesInventors: Pradman Qasba, Elizabeth Boeggeman, Boopathy Ramakrishnan
-
Publication number: 20140106400Abstract: The present invention relates to isolated polypeptides having carboxypeptidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.Type: ApplicationFiled: December 12, 2013Publication date: April 17, 2014Inventor: Michael Rey
-
Publication number: 20140106399Abstract: The present invention relates to a method for production and purification of polypeptides. In particular, the present invention relates to a fusion protein comprising a solubility-enhancing peptide tag moiety, a self-aggregating peptide moiety and a moiety of target peptide and to a method for production and purification of target peptides through expressing said fusion protein.Type: ApplicationFiled: March 15, 2013Publication date: April 17, 2014Inventors: Zhanglin LIN, Wanghui XU, Lei XING, Lingli ZENG, Bihong ZHOU, Qing ZHAO, Wei WU
-
Patent number: 8697844Abstract: The invention relates to a method of purifying PEGylated proteins by removing impurities from samples containing PEGylated proteins, in particular, but not exclusively vitamin K-dependent blood coagulation factors such as Factor IX (FIX), to proteins purified by said method and to the use of said purified proteins in therapy, in particular but not exclusively, for the treatment of diseases alleviated by blood coagulation factors such as the prophylactic treatment of hemophilia.Type: GrantFiled: November 24, 2010Date of Patent: April 15, 2014Assignee: Novo Nordisk A/SInventors: Matthias Karl Dietrich Wiendahl, Lars Sejersgaard, Are Bogsnes
-
Publication number: 20140099667Abstract: An expression vector is disclosed, which comprises: a) a polynucleotide sequence encoding a bacteriorhodopsin or a mutant bacteriorhodopsin; b) a multiple cloning site; c) a T7 promoter, d) a polyhistidine tag; e) a first protease cleavage site; f) optionally a second protease cleavage site; and g) optionally a linker; wherein the mutant bacteriorhodopsin comprises the residue corresponding to Asn94 of SEQ ID NO: 1. Also disclosed is a fusion membrane protein expression system, which comprises: a) a polynucleotide sequence encoding a mutant Haloarcula marismortui bacteriorhodopsin/D94N (HmBRI/D94N) or a Haloquadratum walsbyi bacteriorhodopsin (HwBR); b) a target membrane protein; and c) a T7 promoter, operably linked to the mutant HmBRI/D94N or HwBR and the target membrane protein. Host cells comprising the expression vector or the fusion membrane protein expression system and methods of using the same are also disclosed.Type: ApplicationFiled: September 30, 2013Publication date: April 10, 2014Applicant: Academia SinicaInventors: Andrew H.-J. WANG, Min-Feng` Hsu, Chii-Shen Yang, Hsu-Yuang Fu
-
Publication number: 20140099666Abstract: The invention provides compositions and methods for producing a biological product from a host cell. In various embodiments, the biological product is a polypeptide, a metabolite, a nutraceutical, a chemical intermediate, a biofuel, a food additive, or an antibiotic. In one aspect, the invention provides for a method for producing a biological product from a host cell. The method generally comprises contacting the cell with a RNA effector molecule, a portion of which is complementary to a target gene, maintaining the cell in a large-scale bioreactor for a time sufficient to modulate expression of the target gene, wherein the modulation enhances production of the biological product from the cell, and isolating the biological product from the cell.Type: ApplicationFiled: July 6, 2010Publication date: April 10, 2014Applicant: ALNYLAM PHARMACEUTICALS, INC.Inventors: Anthony Rossomando, John M. Maraganore, Stuart Pollard, David Kocisko, Muthiah Manoharan, Gregory Hinkle, Brian Bettencourt, Shannon Hogan
-
Publication number: 20140099280Abstract: The present invention discloses novel active polypeptide fragments of human IL-33 corresponding to natural forms generated by the proteases of human neutrophils (cathepsin G, elastase 2, proteinase 3), as well as the use thereof as a drug, in particular for the treatment of infectious diseases, inflammatory diseases, atherosclerosis, cardiovascular diseases, obesity, or cancer.Type: ApplicationFiled: February 24, 2012Publication date: April 10, 2014Applicant: Cenre National De La Recherche ScientifiqueInventors: Jean-Philippe Girard, Corinne Cayrol-Girard, Emma Lefraancais
-
Patent number: 8691515Abstract: Disclosed herein are methods of detecting blood disorders, such as diabetes. In particular examples the method includes contacting a blood sample with an amine reagent, blocking an excess of the amine reagent with a blocking reagent, digesting the modified blood sample with trypsin to produce a digested blood sample containing a plurality of glycated N-terminal peptides and non-glycated N-terminal peptides, then analyzing the digested blood sample with MALDI MS. Also provided are reagents for use in such methods.Type: GrantFiled: July 7, 2010Date of Patent: April 8, 2014Assignee: UVic Industry Partnerships Inc.Inventors: Evgeniy V. Petrotchenko, Christoph Borchers
-
Patent number: 8691526Abstract: Biomass feedstocks (e.g., plant biomass, animal biomass, and municipal waste biomass) are processed to produce useful products, such as fuels. For example, systems are described that can convert feedstock materials to a sugar solution, which can then be fermented to produce ethanol. Biomass feedstock is saccharified in a vessel by operation of a jet mixer, the vessel also containing a liquid medium and a saccharifying agent.Type: GrantFiled: November 18, 2010Date of Patent: April 8, 2014Assignee: Xyleco, Inc.Inventors: Marshall Medoff, Thomas Craig Masterman
-
Publication number: 20140093912Abstract: A method of preparing a crosslinked, collagen-based medical scaffold is provided, comprising: (a) immersing a sample of fibrous and/or non-fibrous collagen in a buffered acidic, aqueous solution comprising an alcohol; (b) contacting the collagen in solution with a catalytic component comprising 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride for a time at least sufficient to effect reaction between amino and carboxyl groups present on the collagen and to yield crosslinked collagen that is resistant to pronase degradation; and (c) drying the crosslinked collagen to yield a porous, crosslinked collagen article wherein the porous, crosslinked collagen article demonstrates a pore size of 10-500 microns. Also provided are bioactive collagen medical scaffolds for wound care dressings, hernia repair prosthetics, and surgical incision closure members, prepared using the method above.Type: ApplicationFiled: September 30, 2013Publication date: April 3, 2014Inventors: Ali HUSSAIN, Patrick Cahalan, Linda Cahalan
-
Patent number: 8679771Abstract: This invention provides general methods for selective labeling of proteins on their N-termini with synthetic peptides. The methods of this invention can be applied to the global proteomic profiling of complex mixtures of proteins and polypeptides.Type: GrantFiled: January 24, 2008Date of Patent: March 25, 2014Assignee: The Regents of the University of CaliforniaInventors: James A. Wells, Sami Mahrus
-
Publication number: 20140080175Abstract: The invention described herein pertains to processes for preparing tubulysin derivatives, conjugates of tubulysins, and intermediates therefore.Type: ApplicationFiled: March 15, 2013Publication date: March 20, 2014Applicant: ENDOCYTE, INC.Inventor: ENDOCYTE, INC.
-
Publication number: 20140081007Abstract: This invention relates to non-radioactive markers that facilitate the detection and analysis of nascent proteins translated within cellular or cell-free translation systems. Nascent proteins containing these markers can be rapidly and efficiently detected, isolated and analyzed without the handling and disposal problems associated with radioactive reagents. Preferred markers are dipyrrometheneboron difluoride (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) dyes.Type: ApplicationFiled: August 22, 2013Publication date: March 20, 2014Applicant: Ambergen, Inc.Inventors: Kenneth J. Rothschild, Sadanand Gite, Jerzy Olejnik
-
Publication number: 20140073575Abstract: Prolyl and lysyl hydroxylases isolated from Mimivirus are described. These are able to hydroxylate collagen. Isolated nucleic acids coding for the mentioned hydroxylases are incorporated into suitable vectors and used to express these hydroxylases in host cells, e.g. E. coli. Furthermore a method of manufacturing hydroxylated collagen in a host cell is described. The hydroxylases and the recombinantly expressed hydroxylated collagen are useful in clinical settings and biotechnology applications.Type: ApplicationFiled: March 21, 2012Publication date: March 13, 2014Applicant: UNIVERSITAET ZUERICH PROREKTORAT MNWInventors: Thierry Hennet, Christoph Rutschmann, Kelvin Luther
-
Publication number: 20140073764Abstract: The present invention relates to unnatural amino acids comprising a cyclooctynyl or trans-cyclooctenyl analog group and having formula (I) or an acid or base addition salt thereof. The invention also relates to the use of said unnatural amino acids, kits and processes for preparation of polypeptides that comprise one or more than one cyclooctynyl or trans-cyclooctenyl analog group. These polypeptides can be covalently modified by in vitro or in vivo reaction with compounds comprising an azide, nitrile oxide, nitrone, diazocarbonyl or 1,2,4,5-tetrazine group.Type: ApplicationFiled: February 3, 2012Publication date: March 13, 2014Applicant: EMBLInventors: Edward Lemke, Carsten Schultz, Tilman Plass, Sigrid Milles, Christine Koehler
-
Publication number: 20140073005Abstract: The present invention relates to the field of glycosylation engineering of proteins. More particularly, the present invention relates to nucleic acid molecules, including fusion constructs, having catalytic activity and the use of same in glycosylation engineering of host cells to generate polypeptides with improved therapeutic properties, including antibodies with increased Fc receptor binding and increased effector function.Type: ApplicationFiled: February 5, 2013Publication date: March 13, 2014Applicant: ROCHE GLYCART AGInventor: ROCHE GLYCART AG
-
Publication number: 20140072650Abstract: Disclosed is an antihypertensive composition containing as an active ingredient a gelatin extract made from the skins of a skate ray and a peptide isolated from the extract. The present invention is directed to a pharmaceutical composition for a hypertension prevention and therapy containing as an active ingredient a hydrolysate of a gelatin extract isolated from the skins of a skate ray, a method for preparing a hydrolysate of a gelatin extract made from the skins of a skate ray, and the use of a new peptide having an antihypertensive activity isolated and purified from the hydrolysate.Type: ApplicationFiled: October 31, 2012Publication date: March 13, 2014Applicant: Pukyong National University Industry-University Cooperation FoundationInventors: Se-Kwon KIM, Bo-Mi RYU
-
Publication number: 20140072992Abstract: Methods for detection of the activity of proteolytic enzymes, particularly isopeptidases, are disclosed.Type: ApplicationFiled: August 26, 2013Publication date: March 13, 2014Applicants: Progenra, Inc., Lifesensors, Inc.Inventors: Dattananda Chelur, Michael Eddins, Craig Leach, Steven J. Orcutt, Raymond J. Peroutka, James Strickler, Yilin Yan, Kathryn Longenecker
-
Publication number: 20140073767Abstract: A protein complex comprising (i) a first fusion protein comprising (a) a first polypeptide that comprises a first antigen-binding site and (b) a first binding protein linked to a terminus of the first polypeptide; and (ii) a second fusion protein comprising (a) a second polypeptide that comprises a second antigen-binding site and (b) a second binding protein linked to a terminus of the second polypeptide, wherein the protein complex comprises an amino acid sequence that enables cleavage between the first polypeptide and the first binding protein, and/or between the second polypeptide and the second binding protein, as well as a method for preparing a bi-specific antibody and related methods and compositions.Type: ApplicationFiled: September 11, 2013Publication date: March 13, 2014Inventors: Jung-wook Lee, Min-Kyung KIM, Seon-hui SHIM, Jae-il LEE
-
Publication number: 20140066598Abstract: Provided herein are modified amino acids comprising an azido group, polypeptides, antibodies and conjugates comprising the modified amino acids, and methods of producing the polypeptides, antibodies and conjugates comprising the modified amino acids. The polypeptides, antibodies and conjugates are useful in methods of treatment and prevention, methods of detection and methods of diagnosis.Type: ApplicationFiled: August 30, 2013Publication date: March 6, 2014Applicant: Sutro Biopharma, Inc.Inventors: Ryan Stafford, Christopher D. Thanos, Wenjin Yang
-
Publication number: 20140066359Abstract: According to a first aspect, hydrolysis of a protein-containing raw material and separation of amino acids/peptides is carried out, wherein the hydrolysis is effected by using the endogenous enzymes of the protein-containing raw material. The hydrolysate is passed through a membrane filter, wherein peptide/amino acids follow a permeate stream, whilst the active enzymes continuously break down any protein residues that are deposited on the membrane surface. The enzymes are passed together with retentate back to the hydrolysis. Furthermore, an amino acid and peptide product and an oil product are described and the use thereof is disclosed.Type: ApplicationFiled: November 10, 2013Publication date: March 6, 2014Applicant: Zymtech Production ASInventor: Tomas Carlsson
-
Publication number: 20140057317Abstract: Strategies, systems, methods, reagents, and kits for the directed evolution of bond-forming enzymes are provided herein. Evolution products, for example, evolved sortases exhibiting enhanced reaction kinetics and/or altered substrate preferences are also provided herein, as are methods for using such evolved bond-forming enzymes. Kits comprising materials, reagents, and cells for carrying out the directed evolution methods described herein are also provided.Type: ApplicationFiled: June 20, 2013Publication date: February 27, 2014Applicant: President and Fellows of Harvard CollegeInventors: David R. Liu, Irwin Chen, Brent M. Dorr
-
Publication number: 20140057318Abstract: The present disclosure relates to a field of recombinant DNA therapeutics. It involves the bio-informatics design, synthesis of artificial gene for human insulin precursor including leader peptide coding sequence, cloning in an expression vector and expression in an organism, preferably Pichia pastoris. The present disclosure also relates to methods of downstream processing for obtaining protein precursor molecules and subsequent conversion of precursor molecules to functional proteins.Type: ApplicationFiled: August 22, 2013Publication date: February 27, 2014Applicant: BIGTEC PRIVATE LIMITEDInventors: Mulakkapurath Narayanan Manoj, Venkata Ramachandra Rao Vasamsetty, Madhuri Baliga, Kirubakaran Naveen Kumar, Chandrasekhar Bhaskaran Nair, Pillarisetti Venkata Subbarao
-
Publication number: 20140057999Abstract: (Modified) rice endosperm protein is used as novel protective hydrocolloid for active ingredients, especially fat-soluble active ingredients and/or colorants. Included are compositions comprising (modified) rice endosperm protein and at least one active ingredient and to their manufacture, as well as to the (modified) rice endosperm protein itself and its manufacture. These compositions are used for the enrichment, fortification and/or coloration of food, beverages, animal feed, personal care or pharmaceutical compositions, and to food, beverages, animal feed, personal care and pharmaceutical compositions containing such a (modified) rice endosperm protein and such a composition, respectively.Type: ApplicationFiled: February 8, 2013Publication date: February 27, 2014Applicant: DSM IP ASSETS B.V.Inventor: DSM IP ASSETS B.V.
-
Publication number: 20140057316Abstract: The present invention relates to a method for the production and purification of a sialyltransferase polypeptide, in particular a N-Acetylgalactosamine (Gal NAc)-?-2,6-sialyltransferase I (ST6GalNAcI) polypeptide. The method comprises the steps of producing the sialyltransferase polypeptide in a Chinese Hamster Ovary (CHO) cell and purifying the polypeptide with a combination of chromatography steps. The method results in high yield of sialyltransferase polypeptide which is highly pure and active. The obtained sialyltransferase, especially ST6GalNAcI, can be employed for the glycosylation of therapeutic proteins such as G-CSF.Type: ApplicationFiled: February 2, 2011Publication date: February 27, 2014Applicant: BIOGENERIX GMBHInventors: Axel Angermann, Christian Scheckermann, Karsten Schmidt
-
Publication number: 20140057319Abstract: The properties of an Fc-containing protein, for example, an antibody, are controlled by altering the sialylation of the oligosaccharides in the Fc region by transfecting the cell line expressing the Fc-containing protein with a vector sequence encoding a sialidase. The modified Fc-containing proteins have therapeutic utility in diseases or conditions in which it is desirable to control the affinity for one or more of the Fc?RI, Fc?RIIA, and Fc?RIIIA receptors, ADCC activity, macrophage or monocyte activation, serum half-life, and avidity.Type: ApplicationFiled: August 23, 2013Publication date: February 27, 2014Inventors: Michael Naso, T.Shantha Raju, Bernard Scallon
-
Patent number: 8658394Abstract: The present disclosure pertains to methods of incorporating one or more non-canonical amino acids into a protein during a translation of the protein in bacterial cells. The present disclosure also pertains to methods of incorporating one or more non-canonical amino acids into a protein during an in vitro translation of the protein. In additional embodiments, the present disclosure pertains to isolated bacterial cells and in vitro translation systems (e.g., cell-free extract systems) for incorporating one or more non-canonical amino acids into a protein during a translation of the protein.Type: GrantFiled: January 18, 2012Date of Patent: February 25, 2014Assignee: Waterstone PharmaceuticalsInventors: Ying Huang, Wenshe Liu
-
Publication number: 20140051106Abstract: The present invention relates to assays for monitoring activity of OGFOD1 activity, in particular, to assays for identifying modulators of OGFOD1 activity. The invention also relates to assays to monitor the prolyl hydroxylase activity of OGFOD1 on its substrate, the human ribosomal protein RPS23. The invention also enables the introduction of 3-hydroxyprolyl residues into peptides and proteins.Type: ApplicationFiled: February 10, 2012Publication date: February 20, 2014Applicant: Isis Innovation LimitedInventors: Christopher Joseph Schofield, Alexander Wolf, Wei Ge, Armin Thalhammer, Christoph Loenarz, Peter John Ratcliffe, Matthew Edward Cockman
-
Patent number: 8652805Abstract: A molecule trapping method includes forming a fluid bridge between a first reservoir and a second reservoir, translocating a molecule from the first reservoir to the second reservoir through the fluid bridge, detecting when a segment of the molecule is in the fluid bridge, breaking the fluid bridge and forming an a gap between the first and the second reservoirs, thereby trapping a segment of the molecule in the gap and making measurements on the segment of the molecule.Type: GrantFiled: August 15, 2011Date of Patent: February 18, 2014Assignee: International Business Machines CorporationInventors: Venkat S. K. Balagurusamy, Stanislav Polonsky
-
Publication number: 20140045753Abstract: The present invention relates to novel polypeptides, methods for their synthesis, pharmaceutical compositions comprising the novel polypeptides as well as their use in medicaments for therapeutic applications.Type: ApplicationFiled: October 15, 2013Publication date: February 13, 2014Applicant: NOVO NORDISK HEALTH CARE AGInventors: Bernd Peschke, Magali Zundel
-
Publication number: 20140045930Abstract: The present invention relates to assays for monitoring activity of YcfD activity, in particular, to assays for identifying modulators of YcfD activity. The present invention also relates to the use of YcfD inhibitors as antibiotics. The invention also relates to methods for introducing hydroxyarginine residues into proteins.Type: ApplicationFiled: January 30, 2012Publication date: February 13, 2014Inventors: Christopher Joseph Schofield, Chia-Hua Ho, Alexander Wolf, Wei Ge
-
Publication number: 20140045211Abstract: The present technology relates to the fields of biochemistry, molecular biology and medicine. In particular, the present technology relates to methods and compositions for increased expression of recombinant proteins.Type: ApplicationFiled: March 22, 2012Publication date: February 13, 2014Applicant: The Regents of the University of CaliforniaInventors: Tracy M. Handel, Andrew Douglas
-
Publication number: 20140044698Abstract: The invention relates to new method of peptide hydrolysis, in particular of the cell walls of Gram-positive bacteria, wherein the active form of LytM or derivative thereof is contacted with a peptide substrate, preferably with the cell walls of Gram-positive bacteria, in an aqueous environment of conductivity lower than 10 mS/cm. The invention also relates to composition comprising active form of LytM or derivative thereof and new uses of active form of LytM or derivative thereof.Type: ApplicationFiled: October 17, 2013Publication date: February 13, 2014Applicant: MIEDZYNARODOWY INSTYTUT BIOLOGII MOLEKULARNEJ I KOMORKOWEJInventors: Izabela Sabala, Matthias Bochtler
-
Publication number: 20140039159Abstract: A method of manufacturing a biopolymer optical device includes providing a polymer, providing a substrate, casting the polymer on the substrate, and enzymatically polymerizing an organic compound to generate a conducting polymer between the provided polymer and the substrate. The polymer may be a biopolymer such as silk and may be modified using organic compounds such as tyrosines to provide a molecular-level interface between the provided bulk biopolymer of the biopolymer optical device and a substrate or other conducting layer via a tyrosine-enzyme polymerization. The enzymatically polymerizing may include catalyzing the organic compound with peroxidase enzyme reactions. The result is a carbon-carbon conjugated backbone that provides polymeric “wires” for use in polymer and biopolymer optical devices. An all organic biopolymer electroactive material is thereby provided that provides optical functions and features.Type: ApplicationFiled: July 11, 2013Publication date: February 6, 2014Inventors: David L. KAPLAN, Fiorenzo OMENETTO, Brian LAWRENCE, Mark CRONIN-GOLOMB
-
Publication number: 20140038834Abstract: The present invention relates to a biomarker for the detection of brain damage or a disease associated with loss of neurons, said biomarker comprising a protein fragment of the neurofilament heavy chain (NfH) protein in a biological sample, wherein said protein fragment is a polypeptide selected from the group consisting of i) a polypeptide having the amino acid sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, and polypeptides composed of amino acids 476-1026 and 476-986 of SEQ ID NO 6; ii) a protein fragment of the NfH protein having an amino acid sequence that is at least 60% identical to SEQ ID NO:1, at least 60% identical to SEQ ID NO:2, at least 60% identical to SEQ ID NO:3, at least 60% identical to SEQ ID NO:4, at least 60% identical to SEQ ID NO:5; or at least 60% identical to a polypeptide composed of amino acids 476-1026 and.Type: ApplicationFiled: July 7, 2011Publication date: February 6, 2014Applicant: VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIËNTENZORGInventor: Axel Franz Siegfried Petzold
-
Publication number: 20140030759Abstract: The present specification discloses expression constructs comprising single-chain proteins comprising a di-chain loop region comprising an exogenous protease cleavage site and a protease that can cleave the exogenous protease cleavage site located within the di-chain loop, cell compositions comprising such expression construct, and intracellular methods of converting the single-chain protein into its di-chain form.Type: ApplicationFiled: September 26, 2013Publication date: January 30, 2014Applicant: Allergan, Inc.Inventors: Sanjiv Ghanshani, Linh Q. Le, Yi Liu, Lance E. Steward
-
Publication number: 20140030215Abstract: Pharmaceutical compositions including macrophage activating factor (MAF) and method of producing same, particularly to MAF compositions essentially devoid of glycosidase enzymes. The compositions of the present invention and pharmaceutical compositions including same are particularly suitable for intravenous administration.Type: ApplicationFiled: October 7, 2013Publication date: January 30, 2014Inventor: Nobuto Yamamoto
-
Publication number: 20140030758Abstract: Provided is a method capable of producing a protein at a high level using a cultured animal cell, comprising culturing a cell that expresses APES (Antibody Production Enhancing Sequence) and into which a DNA encoding a desired polypeptide has been introduced, thereby producing the desired polypeptide. APES contains a nucleotide sequence related to NfkBia and has a function of decreasing the intracellular expression of NfkBia.Type: ApplicationFiled: March 30, 2012Publication date: January 30, 2014Applicant: CHUGAI SEIYAKU KABUSHIKI KAISHAInventors: Hisahiro Tabuchi, Tomoya Sugiyama
-
Patent number: 8637306Abstract: Provided are methods of making carrier polypeptide that include incorporating a first unnatural amino acid into a carrier polypeptide variant, incorporating a second unnatural amino acid into a target polypeptide variant, and reacting the first and second unnatural amino acids to produce the conjugate. Conjugates produced using the provided methods are also provided. In addition, orthogonal translation systems in methylotrophic yeast and methods of using these systems to produce carrier and target polypeptide variants comprising unnatural amino acids are provided.Type: GrantFiled: December 9, 2009Date of Patent: January 28, 2014Assignee: The Scripps Research InstituteInventors: Travis Young, Peter G. Schultz
-
Publication number: 20140020694Abstract: A method of modifying the content of certain chemical compounds in tobacco materials is provided, the method including treatment of a tobacco plant or portion thereof with at least one enzyme. For example, the method may modify the content of tobacco smoke toxicant precursors in tobacco materials, which can result in a modification in toxicant production when the tobacco material is exposed to elevated temperatures. The type of tobacco plant or portion thereof treated according to the invention can be, for example, a tobacco seed, a tobacco seedling, an immature live plant, a mature live plant, a harvested plant, or a plant derivative. Smoking articles and other tobacco products including such enzyme-treated tobacco materials are also provided.Type: ApplicationFiled: July 19, 2012Publication date: January 23, 2014Inventors: Serban C. Moldoveanu, Jerry Wayne Marshall, Marvin Glenn Riddick, Michael F. Davis
-
Publication number: 20140024067Abstract: The invention relates to a fusion DNA construct comprising a KEX2 region comprising a KEX2 site and a KEX2 site pre-sequence immediately 5? to the KEX2 site, a fusion polypeptide, vectors and cells comprising the fusion DNA construct, methods for producing desired proteins from filamentous fungal cells and methods for enhancing the secretion and/or cleavage of a desired protein from a cell.Type: ApplicationFiled: July 3, 2013Publication date: January 23, 2014Applicant: Danisco US Inc.Inventors: Huaming Wang, Michael Ward
-
Publication number: 20140024075Abstract: Provided herein are methods and compositions for bacterial cellulose production. In some embodiments, the methods and compositions involve or are made from distiller's grain.Type: ApplicationFiled: May 15, 2012Publication date: January 23, 2014Applicant: Shanghai Zhiyi Information Technology Ltd.Inventor: Feng Hong
-
Patent number: 8632993Abstract: The present invention relates to the use of at least one peptide comprising or consisting of a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4 and SEQ ID NO: 5, for determining the presence of extracts from at least one grass species in a composition.Type: GrantFiled: April 30, 2010Date of Patent: January 21, 2014Assignee: Stallergenes S.A.Inventors: Philippe Moingeon, Thierry Batard, Emmanuel Nony
-
Publication number: 20140017725Abstract: The present invention is in the fields of nanotechnology and biomimetics. In particular, the present invention relates to the use of modified ribosomes to produce biomimetic structures. These biomimetic structures, also known as directed element polymers, are not produced by traditional industrial means but instead are produced by living systems comprising modified ribosomes.Type: ApplicationFiled: February 1, 2013Publication date: January 16, 2014Inventor: Alexander SUNGUROFF
-
Patent number: 8628690Abstract: A nanoemulsion composition having enhanced oxidative stability, emulsion stability, and health benefits. The composition may include individual ingredients or a synergistic blend of non-reducing sugars, sugar polyols, medium-chain triglycerides, polysaccharides, polyphenols, phospholipids, chitosan, and alpha-casein, beta-casein, kappa-casein or protein fragments, glycopeptides, phosphopeptides. The composition may optionally be further utilized for the prevention of hypercholesterolemia or bone (and teeth) mineral loss.Type: GrantFiled: January 3, 2006Date of Patent: January 14, 2014Assignee: The Texas A&M University SystemInventors: Adela Mora-Gutierrez, Michael H Gurin
-
Publication number: 20140011742Abstract: A process for treating a protein before hydrolytic digestion, the process comprising exposing the protein to at least one cycle of microwave irradiation to produce a microwave treated protein containing one or more bioactive peptides. Further hydrolyzing the microwave treated protein to release at least one of the one or more bioactive peptides. A pharmaceutical composition, supplement and food product including the microwave treated protein or the one or more released bioactive peptides.Type: ApplicationFiled: December 8, 2011Publication date: January 9, 2014Applicant: MCGILL UNIVERSITYInventors: Jacqueline Sedman, Ashraf A. Ismail, Ahmed I. Gomaa